Furanopyrimidine compounds effective as potassium channel inhibitors

Details for Australian Patent Application No. 2005252440 (hide)

Owner Xention Discovery Limited

Inventors Ford, John; Palmer, Nicholas John; Madge, David John; Atherall, John Frederick

Agent FB Rice

Pub. Number AU-A-2005252440

PCT Pub. Number WO2005/121149

Priority 0412986.2 10.06.04 GB; 60/578,350 10.06.04 US

Filing date 10 June 2005

Wipo publication date 22 December 2005

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/121149 Priority application(s): WO2005/121149

23 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005252441-Method for determining biophysical properties

2005252439-Fastening rail in railway slide chair assembly